New bladder cancer device enters first human tests in japan
NCT ID NCT05567185
Summary
This is an early safety study for a new device called TAR-210, which is placed in the bladder to slowly release a cancer drug. It is being tested in 5 Japanese patients with a specific type of recurring bladder cancer that has certain genetic changes. The main goal is to see how well the device is tolerated and to measure the levels of the drug in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY BLADDER NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Osaka International Cancer Institute
Osaka, 541 8567, Japan
-
St Marianna University Hospital
Kanagawa, 216 8511, Japan
-
Toyama University Hospital
Toyama, 930-0194, Japan
-
University of Tsukuba Hospital
Tsukuba, 305 8576, Japan
Conditions
Explore the condition pages connected to this study.